Check Claims Before You Publish

Key high‑impact works (selected)

• sAA biomarker review (2009)
• sAA stress reactivity (2005)
• sAA diurnal determinants (2007)
• Music & stress (2013)

Evidence‑based critique (claims with sources)

1. Scientific influence: Author metrics indicate substantial impact: OpenAlex lists ~740 works and ~15,391 total citations with h‑index ≈53 — consistent with a sustained, high‑output career focused on psychoneuroendocrinology and stress biomarkers (visualized above). The author’s most cited work establishes sAA as a commonly used sympathetic biomarker (sAA review (2009)).
2. Methodological rigor: Multiple methodological papers (2007, 2009) explicitly discuss assay variability, diurnal effects, and sampling control — evidence the author emphasizes measurement quality and reproducibility (sAA determinants (2007)).
3. Reproducibility & replicability: The large number of empirical studies (laboratory TSST paradigms, field sampling) and multiple reviews suggest internal reproducibility of the sAA literature; nevertheless, across‑study heterogeneity in assays and small N in some experimental arms constrain external replication strength (sAA stress reactivity (2005)).
4. Breadth vs. depth: Nater’s portfolio shows depth in stress biomarkers and psychophysiology plus applied studies (e.g., music and stress) and psychometric scale work — this breadth is a strength for translational psychobiology but raises the question of clinical causal inference when moving from lab markers to health outcomes (Music intervention (2013)).
5. Potential blindspots & biases: Most high‑impact contributions are observational or acute experimental studies of stress reactivity; fewer large prospective, clinically powered trials tie sAA variation to hard health endpoints (cardiovascular events, long‑term disease) — a common gap in biomarker fields that limits direct clinical application (see methodological reviews above for cautionary notes) (sAA review limitations (2009)).
6. Openness & accessibility: Several of Nater’s empirical papers are open access (e.g., 2013 PLoS ONE), and he is co‑author on multiple reviews and methods papers — sign of good community sharing. However, not all foundational reviews are open, which reduces immediate reproducibility for some readers (Open access applied trial).

Practical takeaways for a researcher reading Nater's body of work

• Use sAA as a practical, time‑sensitive marker of sympathetic/reactive autonomic function — but implement strict sampling and assay controls (flow rate, time of day, oral health) as recommended in Nater’s reviews (sAA sampling guidance).
• When translating to clinical endpoints, pair sAA with longitudinal outcome data and other physiological markers (e.g., catecholamines, HRV) because single cross‑sectional biomarker studies can overstate predictive power (sAA determinants for translation).

Buttons — continue analysis

Limitations of this review / known unknowns

• Numbers (works_count, cited_by) were taken from OpenAlex snapshots; author disambiguation and multiple profiles can slightly change counts.
• Citation counts do not measure methodological correctness; influential reviews can be widely cited for both supportive and critical reasons.
• Clinical translation gaps reflect the broader biomarker field, not necessarily errors by the author; longitudinal endpoint studies are limited across the literature.

Representative citations used in this review

• sAA review (2009)
• sAA stress reactivity (2005)
• sAA diurnal determinants (2007)
• Music intervention trial (2013)